SBI Healthcare Opportunities Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.76%)Nav, as on 23-01-2026

  • Previous Nav

  • Net Change on 23-01-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH -5.01 -8.46 -3.86 21.82 15.32 15.65
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 -3.86 21.82 15.32 1.93 3,989.42
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -2.42 19.73 14.10 1.82 8,264.71
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 -2.53 24.95 16.37 1.86 6,455.55
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -7.25 19.16 14.12 1.92 3,114.33
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -3.81 19.49 14.36 1.93 2,770.84
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -5.10 19.68 13.87 2.10 1,310.50

Fund Holdings as on 31-December-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Lupin Ltd.

  • Laurus Labs Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Acutaas Chemicals Ltd.

  • Cipla Ltd.

  • Lonza Group

  • TREPS

  • Biocon Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Fortis Healthcare Ltd.

  • Aster DM Healthcare Ltd.

  • Aether Industries Ltd.

  • Mankind Pharma Ltd.

  • Abbott India Ltd.

  • Alkem Laboratories Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Polymedicure Ltd.

  • Gland Pharma Ltd.

  • Concord Biotech Ltd.

  • Anthem Biosciences Ltd.

  • Aurobindo Pharma Ltd.

  • Sudeep Pharma Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • Cohance Lifesciences Ltd.

  • Pfizer Ltd.

  • Medplus Health Services Ltd.

  • Nephrocare Health Service Pvt. Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • Gufic Biosciences Ltd.

  • Corona Remedies Ltd.

  • 364 DAY T-BILL 19.11.26

  • Net Receivable / Payable

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Retailing

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 14-Jul-1999 and currently has an AUM of ₹3,989.42 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended down ₹-3.09(-0.76%)yesterday to ₹403.174.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051

022 - 61793537
022 - 22189663
www.sbimf.com